TABLE 1.
Activity of antifungal agents tested using the CLSI reference broth microdilution method against fungal organism groups according to clinical breakpoints and/or ECV interpretative criteriaa
| Organism (no. of isolates tested) and antifungal agent | MIC50 or MEC50 (μg/ml) | MIC90 or MEC90 (μg/ml) | % of isolates |
|||
|---|---|---|---|---|---|---|
| CLSI method |
ECV |
|||||
| S | R | WT | NWT | |||
| C. albicans (1,310) | ||||||
| Anidulafungin | 0.015 | 0.03 | 99.9 | 0.0 | 99.8 | 0.2 |
| Caspofungin | 0.015 | 0.03 | 99.8 | 0.2 | ||
| Micafungin | 0.015 | 0.03 | 99.8 | 0.2 | 99.8 | 0.2 |
| Fluconazole | ≤0.12 | 0.25 | 99.6 | 0.4 | ||
| Voriconazole | ≤0.008 | 0.015 | 99.9 | <0.1 | ||
| Posaconazole | 0.03 | 0.06 | ||||
| Amphotericin B | 1 | 1 | 100.0 | 0.0 | ||
| C. glabrata (514) | ||||||
| Anidulafungin | 0.06 | 0.12 | 95.9 | 2.5 | 97.5 | 2.5 |
| Caspofungin | 0.03 | 0.06 | 96.9 | 2.5 | ||
| Micafungin | 0.015 | 0.03 | 97.5 | 2.3 | 96.9 | 3.1 |
| Fluconazole | 4 | 16 | 92.0b | 8.0 | ||
| Voriconazole | 0.12 | 0.5 | ||||
| Posaconazole | 0.5 | 1 | ||||
| Amphotericin B | 1 | 1 | 100.0 | 0.0 | ||
| C. parapsilosis (417) | ||||||
| Anidulafungin | 2 | 4 | 88.7 | 0.0 | 100.0 | 0.0 |
| Caspofungin | 0.25 | 0.5 | 100.0 | 0.0 | ||
| Micafungin | 1 | 2 | 100.0 | 0.0 | 100.0 | 0.0 |
| Fluconazole | 0.5 | 2 | 95.7 | 3.8 | ||
| Voriconazole | 0.015 | 0.03 | 96.4 | 0.7 | ||
| Posaconazole | 0.06 | 0.12 | ||||
| Amphotericin B | 1 | 1 | 100.0 | 0.0 | ||
| C. tropicalis (264) | ||||||
| Anidulafungin | 0.015 | 0.03 | 100.0 | 0.0 | 100.0 | 0.0 |
| Caspofungin | 0.015 | 0.06 | 100.0 | 0.0 | ||
| Micafungin | 0.015 | 0.06 | 100.0 | 0.0 | 99.6 | 0.4 |
| Fluconazole | 0.25 | 0.5 | 96.2 | 2.7 | 96.2 | 3.8 |
| Voriconazole | 0.015 | 0.06 | 97.0 | 2.3 | ||
| Posaconazole | 0.03 | 0.12 | ||||
| Amphotericin B | 1 | 1 | 100.0 | 0.0 | ||
| C. krusei (93) | ||||||
| Anidulafungin | 0.06 | 0.12 | 100.0 | 0.0 | 100.0 | 0.0 |
| Caspofungin | 0.12 | 0.25 | 100.0 | 0.0 | ||
| Micafungin | 0.06 | 0.12 | 100.0 | 0.0 | 100.0 | 0.0 |
| Fluconazole | 32 | 64 | ||||
| Voriconazole | 0.25 | 0.5 | 100.0 | 0.0 | ||
| Posaconazole | 0.25 | 0.5 | ||||
| Amphotericin B | 1 | 2 | 100.0 | 0.0 | ||
| C. dubliniensis (58) | ||||||
| Anidulafungin | 0.03 | 0.12 | 100.0 | 0.0 | ||
| Caspofungin | 0.03 | 0.06 | ||||
| Micafungin | 0.03 | 0.06 | 100.0 | 0.0 | ||
| Fluconazole | ≤0.12 | 0.25 | ||||
| Voriconazole | ≤0.008 | 0.015 | ||||
| Posaconazole | 0.03 | 0.06 | ||||
| Amphotericin B | 0.5 | 1 | ||||
| C. lusitaniae (39) | ||||||
| Anidulafungin | 0.25 | 0.5 | 100.0 | 0.0 | ||
| Caspofungin | 0.12 | 0.25 | ||||
| Micafungin | 0.12 | 0.25 | 100.0 | 0.0 | ||
| Fluconazole | 0.5 | 1 | ||||
| Voriconazole | ≤0.008 | ≤0.008 | ||||
| Posaconazole | 0.06 | 0.12 | ||||
| Amphotericin B | 0.5 | 1 | ||||
| C. guilliermondii (14) | ||||||
| Anidulafungin | 2 | 4 | 92.9 | 0.0 | 100.0 | 0.0 |
| Caspofungin | 0.5 | 1 | 100.0 | 0.0 | ||
| Micafungin | 1 | 1 | 100.0 | 0.0 | 100.0 | 0.0 |
| Fluconazole | 2 | 64 | ||||
| Voriconazole | 0.06 | 1 | ||||
| Posaconazole | 0.5 | >8 | ||||
| Amphotericin B | 0.25 | 1 | ||||
| A. fumigatus (391) | ||||||
| Anidulafungin | ≤0.008 | 0.03 | ||||
| Caspofungin | 0.015 | 0.03 | 100.0 | 0.0 | ||
| Micafungin | ≤0.008 | 0.015 | ||||
| Itraconazole | 0.5 | 1 | 99.5 | 0.5 | ||
| Voriconazole | 0.5 | 0.5 | 99.7 | 0.3 | ||
| Posaconazole | 0.25 | 0.5 | ||||
| Amphotericin B | 1 | 2 | 100.0 | 0.0 | ||
| A. niger (15) | ||||||
| Anidulafungin | ≤0.008 | 0.03 | ||||
| Caspofungin | 0.015 | 0.03 | 100.0 | 0.0 | ||
| Micafungin | ≤0.008 | 0.015 | ||||
| Itraconazole | 0.5 | 1 | 100.0 | 0.0 | ||
| Voriconazole | 0.5 | 0.5 | 100.0 | 0.0 | ||
| Posaconazole | 0.25 | 0.5 | 100.0 | 0.0 | ||
| Amphotericin B | 1 | 2 | 100.0 | 0.0 | ||
| A. terreus (12) | ||||||
| Anidulafungin | ≤0.008 | 0.03 | ||||
| Caspofungin | 0.015 | 0.03 | 100.0 | 0.0 | ||
| Micafungin | ≤0.008 | 0.015 | ||||
| Itraconazole | 0.5 | 1 | 100.0 | 0.0 | ||
| Voriconazole | 0.5 | 0.5 | 100.0 | 0.0 | ||
| Posaconazole | 0.25 | 0.5 | 100.0 | 0.0 | ||
| Amphotericin B | 1 | 2 | 100.0 | 0.0 | ||
MEC50 and MEC90, minimum effective concentrations for 50% and 90% of isolates, respectively; CLSI, Clinical and Laboratory Standards Institute; S, susceptible; R, resistant; ECV, epidemiologic cutoff value; WT, wild-type; NWT, non-wild-type.
Susceptible dose dependent.